Vitassay Healthcare

What Vitassay Healthcare does

Vitassay Healthcare, S.L.U. is a privately held Spanish in vitro diagnostic (IVD) manufacturer founded in 2015 and headquartered at the Walqa Technology Park in Huesca, Spain. The company builds three core diagnostic platforms: a Rapid Test line of point-of-care immunodiagnostic kits, a qPCR line of molecular diagnostic assays delivered in lyophilized (freeze-dried) format with extended shelf life and room-temperature stability, and a Turbidimetric Assay line of automated, quantitative clinical chemistry tests. Its molecular portfolio includes multiplex assays that detect multiple respiratory, tropical, and rodent-borne pathogens (including hantavirus variants such as Andes virus), targeting differential diagnosis of infectious diseases with overlapping symptoms.

The company sells its kits directly to clinical and research laboratories and to healthcare professionals worldwide, supplemented by a recurring presence at major laboratory medicine trade shows (ADLM in North America, MEDICA in Europe, WHX Labs in Dubai). Its marketing is concentrated on the corporate website, LinkedIn, and event participation, with pricing and customer-specific contracts handled off-line through direct contact. Manufacturing is conducted under an ISO 13485:2016 quality management system that was recertified in 2025, and the firm cites distribution across multiple languages, regulatory regimes, and time zones as evidence of its global footprint, although it discloses no institutional investors, parent entity, or management team in the available data.

Commercially, the business is small and bootstrapped in appearance: headcount is reported at 1–10 employees, no funding rounds, partnerships, M&A, or revenue figures have been disclosed, and ownership is privately held with no public ticker. Its 10-year operating history, sustained trade-show cadence, and ongoing product launches (most recently the qPCR Andes virus RUO kit and forthcoming Hantavirus PCR Detection Kit in June 2026) indicate a niche, product-focused IVD specialist competing on lyophilized-format molecular chemistry, automated turbidimetry, and emerging infectious-disease menu breadth rather than on scale, platform software, or distribution exclusivity.

Name

Vitassay Healthcare

Legal name

Vitassay Healthcare, S.L.U.

Website

https://vitassay.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industry

Immunoassay Diagnostics (ELISA, chemiluminescence, serology) (HLAAALAB)

Keywords

• In vitro diagnostics
• Rapid test kits
• Molecular diagnostics
• Turbidimetric assays
• Pathogen detection

Headquarters

HQ city

Huesca

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. In Vitro Diagnostic Products: Sale of diagnostic kits including Rapid Tests, qPCR assays, and Turbidimetric assays to healthcare laboratories and professionals worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Vitassay Healthcare manufactures and sells in vitro diagnostic (IVD) kits across three proprietary technology platforms: Rapid Test (point-of-care immunodiagnostic tests), qPCR (molecular diagnostic assays in lyophilized format), and Turbidimetric Assay (automated quantitative testing). Products are designed for clinical and research laboratories needing reliable pathogen detection, including multiplex PCR assays for respiratory viruses, hantavirus variants, and tropical diseases.

Product overview

Vitassay Healthcare is an in vitro diagnostic (IVD) product manufacturer founded in 2015, based in Huesca, Spain. The company offers a portfolio of three core diagnostic product lines: Rapid Test (point-of-care immunodiagnostic tests for fast, reliable screening), qPCR (lyophilized molecular diagnostic assays for high-accuracy pathogen detection including respiratory viruses, hantavirus, and tropical diseases), and Turbidimetric Assay (automated quantitative testing for laboratory settings). All products are designed to support healthcare professionals with quality and safety in diagnostic workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• Vitassay Rapid Test Point-of-care rapid immunodiagnostic tests providing reliability, speed, and precision in compact format for clinical screening by healthcare professionals.
• Vitassay qPCR Quantitative PCR diagnostic assays in lyophilized (freeze-dried) format, providing diagnostic accuracy, room-temperature stability, and extended shelf life for molecular testing applications including multiplex pathogen detection.
• Vitassay Turbidimetric Assay Automated turbidimetric testing solutions providing quantitative, accurate, and reproducible results for laboratory diagnostics and workflow optimization.
• Vitassay qPCR Andes virus (RUO) RT-qPCR molecular diagnostic kit for the detection of Andes virus (Hantavirus strain), designed for research use, including an internal housekeeping gene control for monitoring the full sample-to-result workflow.

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• bioMérieux: Global IVD leader with broad portfolios across microbiology, molecular diagnostics (BioFire), and immunoassays — directly comparable to Vitassay's three-platform IVD strategy but at vastly larger scale.
• Hologic: Strong molecular diagnostics franchise (Panther, Aptima) and women's health IVD — comparable molecular assay developer with multiplex respiratory panels competing with Vitassay qPCR.
• Cepheid (Danaher): Gold-standard molecular diagnostics platform (GeneXpert) with extensive respiratory, HAI, and outbreak menu — directly comparable to Vitassay qPCR but bundled with proprietary instruments.
• Roche Diagnostics: Largest global IVD player offering rapid tests, PCR (cobas), and clinical chemistry / turbidimetric immunoassays — overlapping all three of Vitassay's core technology platforms with extensive laboratory reach.
• Abbott Diagnostics: Diversified IVD incumbent with strong rapid diagnostic test (Binax), molecular (Alinity m), and clinical chemistry / immunoassay menu — directly comparable breadth to Vitassay's portfolio.

Direct peers

• DiaSorin: Italian-headquartered IVD specialist with strong molecular (LIAISON) and immunoassay / turbidimetric menu — closely comparable in origin, scale, and product mix to Vitassay.
• Meridian Bioscience: Mid-market IVD manufacturer of molecular (Revogene, Alethia) and immunoassay products — comparable in scale, product breadth, and laboratory customer focus to Vitassay.
• Vircell: Spanish IVD manufacturer based in Granada offering molecular diagnostics, rapid tests, and ELISA kits — a Spanish-headquartered peer with a similar three-platform IVD structure and comparable scale.
• R-Biopharm: Mid-sized German IVD manufacturer focused on clinical diagnostics and food/feed testing with multiplex PCR and immunoassay product lines — comparable mid-market European IVD manufacturer serving laboratories globally.
• QuidelOrtho: Specialist in rapid immunoassay diagnostics (Sofia, Triage) with growing molecular capabilities — directly comparable to Vitassay's Rapid Test platform with broader commercial reach.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/vitassay-healthcare-sl

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vitassay Healthcare